These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10726931)

  • 21. Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: specific inhibition of the Mg(2+)-dependent enzyme and role of isoprenoid chain.
    Martín SF; Gómez-Díaz C; Navas P; Villalba JM
    Biochem Biophys Res Commun; 2002 Sep; 297(3):581-6. PubMed ID: 12270134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Kornhuber J; Tripal P; Reichel M; Terfloth L; Bleich S; Wiltfang J; Gulbins E
    J Med Chem; 2008 Jan; 51(2):219-37. PubMed ID: 18027916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correction of age-related changes in sphingolipid content in rat tissues by acid sphingomyelinase inhibition].
    Har'kavenko VV; Storozhenko GB; Krasnikova OM; Babenko NO
    Fiziol Zh (1994); 2012; 58(1):56-60. PubMed ID: 22590738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel inhibition mechanism of Bacillus cereus sphingomyelinase by beryllium fluoride.
    Fujii S; Nagata M; Morita M; Minoura K; Tsukamoto K; Ikezawa H; Ikeda K
    Arch Biochem Biophys; 2004 Apr; 424(2):201-9. PubMed ID: 15047192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase.
    Wascholowski V; Giannis A; Pitsinos EN
    ChemMedChem; 2006 Jul; 1(7):718-21. PubMed ID: 16902925
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima.
    Nara F; Tanaka M; Masuda-Inoue S; Yamasato Y; Doi-Yoshioka H; Suzuki-Konagai K; Kumakura S; Ogita T
    J Antibiot (Tokyo); 1999 Jun; 52(6):531-5. PubMed ID: 10470676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle.
    Zheng T; Li W; Wang J; Altura BT; Altura BM
    Eur J Pharmacol; 2000 Mar; 391(1-2):127-35. PubMed ID: 10720644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastereoselective synthesis of gamma-amino-delta-hydroxy-alpha,alpha-difluorophosphonates: a vehicle for structure-activity relationship studies on SMA-7, a potent sphingomyelinase inhibitor.
    Yamagishi T; Muronoi S; Hikishima S; Shimeno H; Soeda S; Yokomatsu T
    J Org Chem; 2009 Aug; 74(16):6350-3. PubMed ID: 19610607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins.
    Schoenauer R; Larpin Y; Babiychuk EB; Drücker P; Babiychuk VS; Avota E; Schneider-Schaulies S; Schumacher F; Kleuser B; Köffel R; Draeger A
    FASEB J; 2019 Jan; 33(1):275-285. PubMed ID: 29979630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
    Mehta G; Modugu NR
    J Org Chem; 2013 Apr; 78(7):3367-73. PubMed ID: 23442124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase.
    Hakogi T; Fujii S; Morita M; Ikeda K; Katsumura S
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2141-4. PubMed ID: 15808485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model.
    Yang K; Nong K; Gu Q; Dong J; Wang J
    Eur J Med Chem; 2018 May; 151():389-400. PubMed ID: 29649738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
    Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
    Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. It takes a CAD to kill a tumor cell with a LMP.
    Gulbins E; Kolesnick RN
    Cancer Cell; 2013 Sep; 24(3):279-81. PubMed ID: 24029224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A photocaged inhibitor of acid sphingomyelinase.
    Prause K; Naseri G; Schumacher F; Kappe C; Kleuser B; Arenz C
    Chem Commun (Camb); 2020 Nov; 56(94):14885-14888. PubMed ID: 33179626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by Penicillium sp. FO-7436.
    Uchida R; Tomoda H; Dong Y; Omura S
    J Antibiot (Tokyo); 1999 Jun; 52(6):572-4. PubMed ID: 10470682
    [No Abstract]   [Full Text] [Related]  

  • 37. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
    Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
    Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRM646-A and -B, novel fungal metabolites that inhibit heparinase.
    Ko HR; Kim BY; Oh WK; Kang DO; Lee HS; Koshino H; Osada H; Mheen TI; Ahn JS
    J Antibiot (Tokyo); 2000 Feb; 53(2):211-4. PubMed ID: 10805586
    [No Abstract]   [Full Text] [Related]  

  • 39. Lysosomal accumulation of cholesterol and sphingomyelin: evidence for inhibition of acid sphingomyelinase.
    Bhuvaneswaran C; Venkatesan S; Mitropoulos KA
    Eur J Cell Biol; 1985 May; 37():98-106. PubMed ID: 2992980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthesis of sphingomyelin analogues as a sphingomyelinase inhibitor and the application as a blocking agent of extracellular stress signaling].
    Tsuji Y; Soeda S; Ochiai T; Mishima K; Iwasaki K; Fujiwara M; Yokomatsu T; Murano T; Akiyama T; Shibuya S; Shimeno H
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):67P-69P. PubMed ID: 12491783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.